Hill-Rom Holdings EBIT

As of the most recent data (September 2021), HRC shows a EBIT of $900M. That compares with $410M in the prior-year period — up 118.8% year over year. That is below the Healthcare sector average of $99B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HRC's EBIT is now $900M (was $410M) — a 118.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Hill-Rom Holdings is outperforming or lagging.

The Healthcare sector average EBIT is about $99B. Hill-Rom Holdings is at $900M, which is lower that average. That is roughly 99.1% below the sector mean. Use the comparison chart on this page to see how HRC stacks up against individual peers as well.

Tracking HRC's ebit over time shows whether Hill-Rom Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $900M That compares with $410M in the prior-year period — up 118.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Hill-Rom Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $900M) with ownership activity and broader fundamentals.